Four researchers of Wyeth Pharmaceuticals (10944776), a division of Wyeth (NYSE: WYE) were honored at the Research & Development (R&D) Council of New Jersey 2006 Annual Thomas Alva Edison Patent Awards for a significant scientific breakthrough and revolutionary product innovation originating in New Jersey: 
Christopher P. Miller, Ph.D.; Michael D. Collini; Bach D. Tran; and Arthrur A. Santilli, Ph.D., received the 2006 Thomas Alva Edison Patent Award in the category of Emerging Therapies.
These researchers were granted the patent for bazedoxifene, an investigational selective estrogen receptor modulator for the prevention of postmenopausal osteoporosis.
Find more details from the press release.
.jpg)
Comment Preview